The effect of certolizumab pegol in patients with psoriatic arthritis: The results of RAPID-PsA study_the commentary to the study

Abstract

The article briefly acquaints the reader with the design of the RAPID-PsA study and further with the results of the 24. and 48. week of the follow-up, with the results of X-ray progression, with the assessment of the extraarticular involvement and with the consideration of wheather it is possible to predict the long-term response to the therapy with certolizumab

Keywords

• psoriatic arthritis
• certolizumab pegol
• minimal disease aktivity
• x-ray progression,
• extraarticular involvement